These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Detecting mediastinal lymph node metastases in non-small-cell lung cancer using a combination of technetium-99m tetrofosmin chest single photon emission computed tomography and chest computed tomography. Shiun SC, Sun SS, Hsu NY, Kao CH, Lin CC, Lee CC. Cancer Invest; 2002; 20(3):311-7. PubMed ID: 12025225 [Abstract] [Full Text] [Related]
27. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer. Akgun A, Cok G, Karapolat I, Goksel T, Burak Z. Ann Nucl Med; 2006 May 15; 20(4):269-75. PubMed ID: 16856570 [Abstract] [Full Text] [Related]
31. Prospective study of dual-phase 99mTc-MIBI SPECT/CT nomogram for differentiating non-small cell lung cancer from benign pulmonary lesions. Cheng L, Gao H, Wang Z, Guo L, Wang X, Jin G. Eur J Radiol; 2024 Oct 15; 179():111657. PubMed ID: 39163806 [Abstract] [Full Text] [Related]
33. Comparison of biological properties of 99mTc-labeled cyclic RGD Peptide trimer and dimer useful as SPECT radiotracers for tumor imaging. Zhao ZQ, Yang Y, Fang W, Liu S. Nucl Med Biol; 2016 Nov 15; 43(11):661-669. PubMed ID: 27556955 [Abstract] [Full Text] [Related]
34. Comparative study of Tc-99m MIBI and TI-201 SPECT in predicting chemotherapeutic response in non-small-cell lung cancer. Nishiyama Y, Yamamoto Y, Satoh K, Ohkawa M, Kameyama K, Hayashi E, Fujita J, Tanabe M. Clin Nucl Med; 2000 May 15; 25(5):364-9. PubMed ID: 10795697 [Abstract] [Full Text] [Related]
37. Molecularly targeted therapy using bevacizumab for non-small cell lung cancer: a pilot study for the new CT response criteria. Lee HY, Lee KS, Hwang HS, Lee JW, Ahn MJ, Park K, Kim TS, Yi CA, Chung MJ. Korean J Radiol; 2010 May 15; 11(6):618-26. PubMed ID: 21076587 [Abstract] [Full Text] [Related]
39. Association Between Endothelial Progenitor Cells and Treatment Response in Non-Squamous Non-small Cell Lung Cancer Treated with Bevacizumab. Sudo K, Sato K, Sakamoto S, Hasegawa Y, Asano M, Okuda Y, Takeda M, Sano M, Watanabe H, Shioya T, Ito H. Anticancer Res; 2017 Oct 15; 37(10):5565-5571. PubMed ID: 28982871 [Abstract] [Full Text] [Related]
40. [¹⁸F]FDG positron emission tomography within two weeks of starting erlotinib therapy can predict response in non-small cell lung cancer patients. Hachemi M, Couturier O, Vervueren L, Fosse P, Lacœuille F, Urban T, Hureaux J. PLoS One; 2014 Oct 15; 9(2):e87629. PubMed ID: 24505298 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]